While UBS is positive on Pfizer’s recent Metsera obesity deal, analysts said more business development or acquisitions will be needed. They flagged upcoming Phase II obesity data in early 2026 as a ...

In a major development for obesity treatment, a popular weight-loss medication, Wegovy, is now available in tablet form in ...

The United Kingdom has started enforcing a ban on junk food advertising to help address childhood obesity. Under the new rules, advertisements for unhealthy food and drinks are no longer allowed on ...

UK Bans Junk Food Ads Before 9 PM-World-Leading Obesity Fight! No TV promotions for high-fat/salt/sugar (HFSS) foods like ...

It was a defining moment in weight-loss management after an FDA-approved Wegovy pill is now available and provides another, ...

A new study co-led by the Southern California Superfund Research and Training Program for PFAS Assessment, Remediation and ...

Researchers at Mass General Brigham reveal that nearly 70% of U.S. adults are obese according to a study that was published ...

The weight loss drug Wegovy is now available as a tablet in more than 70,000 U.S. pharmacies as well as select telehealth ...

The oral versions may set records in 2026, and glucagon-like peptide 1 (GLP-1) drugs will pick up even more momentum as ...

Shares of Ventyx Biosciences gained after The Wall Street Journal reported that the company is in advanced talks to be acquired by Eli Lilly for about $1 billion. Ventyx shares were up 5.2%, to $8.23, ...